IHS Chemical Week

DSM looking at options to exit its caprolactam business

11:43 AM MDT | July 3, 2013

DSM today declined to comment on a Bloomberg report that it is considering exiting the caprolactam business. However, it confirmed previously announced plans to reduce its exposure to the merchant caprolactam market. “DSM is considering various options and has nothing new to report to its previous public statements,” the company said. DSM is among the world’s largest merchant sellers of caprolactam, with about 60% of its production at Geelen, Netherlands, and Augusta, GA, being sold to third parties. In addition, a joint venture with Sinopec is building a...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 


Forgot your user ID or password? Click here to have it sent to you.

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa